AMSTERDAM — Corbion has developed a mold inhibition for bakers called Verdad Essence WH100. The ingredient is a cultured wheat solution that is perceived as natural and provides bakers with an ...

The Basel Area in Switzerland is home to one of Europe’s brightest biotech ecosystems. Over the years, it has proven to be the favored location for many of the world’s biggest, best, and newest ...

Officials in Murrysville, which is in the middle of the Turtle Creek Watershed, have worked with the association and helped pursue grants for several years to help put acid mine remediation ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...

Good morning, all. It’s Ben & Jerry's Free Cone Day. Here’s how to grab a free scoop of your favorite flavor today. Now, on to the news. The Supreme Court yesterday cleared the way for ...

Analysts' ratings for Legend Biotech LEGN over the last quarter vary from bullish to bearish, as provided by 5 analysts. The following table encapsulates their recent ratings, offering a glimpse ...

China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. Top of the morning to you, and a fine one it is. Blue skies ...